Reducing the Cost
of
Health Care
During
the 1990s, the U.S. Food and Drug Administration (FDA) compiled
a list of adverse reactions reported to it by MSG-sensitive consumers. Reports included:
|
headache (17.9%) vomiting and nausea (7.7%) diarrhea (5.9%) abdominal pain and cramps (5.4%) change in mood (5.3%) change in heart rate (5.1%) dizziness or balance problems (3.6%) difficulty breathing (3.4%) fatigue/weakness (3.1%) localized pain and tenderness (2.6%) sleep problems (2.5%) change in sensation (numbness, tingling) (2.4%) |
change in body temperature (2.3%) change in vision (2.3%) change in activity level (2.0%) chest pain (1.9%) local swelling (1.8%) difficulty swallowing (1.4%) joint and bone pain (1.3%) blood pressure changes (1.2%) changes in skin and nail coloration (1.2%) other neurological (1.2%) other symptoms (18.8%) |
That could all change if the MSG in processed food was identified on the labels of processed food. If consumers could tell what products contained MSG, and which didn’t, they would be better able to tell if MSG was causing their adverse reactions – and reduce their occurrence. And if the amounts of MSG present were specified, a consumer might learn how much MSG could be consumed before it caused a reaction – again, reducing the occurrence of adverse reactions.
adandjack@aol.com 858/481-9333 http://www.truthinlabeling.org This page was last updated on December 9, 2009.
IF MSG ISN'T HARMFUL, WHY IS IT HIDDEN?